METROGEL 0.75% 0.75 %
METRONIDAZOLE : 0.75 % · DIN 02092832 · GALDERMA CANADA INC
Health Canada status: MARKETED
What is METROGEL 0.75%?
METROGEL 0.75% 0.75 % contains METRONIDAZOLE : 0.75 %. It is listed in the Health Canada Drug Product Database under DIN 02092832, held by GALDERMA CANADA INC, supplied as GEL for TOPICAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1994. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is METROGEL 0.75% used for?
METROGEL (0.75% & 1%)(metronidazole topical gel) is indicated for: topical application in the treatment of inflammatory papules, pustules, and erythema of rosacea.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02092832 |
|---|---|
| Brand name | METROGEL 0.75% |
| Generic / active ingredient | METRONIDAZOLE : 0.75 % |
| Manufacturer | GALDERMA CANADA INC |
| Strength | 0.75 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D06BX01 METRONIDAZOLE |
| AHFS class | 84:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1994 |
| Original market date | 1994-12-31 00:00:00 |
How is it administered?
1%: Apply thin film once daily. 0.75%: Apply thin film twice daily (morning and evening). Areas should be cleansed and dry before application. Significant results usually within 3 weeks.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
METROGEL 1% (metronidazole topical gel): Store at room temperature (15º to 30ºC). METROGEL 0.75% (metronidazole topical gel): Store at 15º to 30ºC.
How is it supplied?
METROGEL 1% is supplied in a 55 g high-density polyethylene (HDPE) bottle with a polypropylene (PP) pump. METROGEL 0.75% (metronidazole topical gel) is supplied in 60 g aluminum tubes.
Contraindications
History of hypersensitivity to metronidazole or other ingredients of the formulations.
Warnings and precautions
Avoid contact with eyes (may cause tearing/conjunctivitis). Use with care in patients with history of blood dyscrasia. Avoid excessive sunlight/UV exposure. Discontinue if local irritation occurs.
Is METRONIDAZOLE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Discontinued — reported by PFIZER CANADA ULC, last seen 19 May 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code D06BX01 METRONIDAZOLE. 3 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| METROGEL 1% | 1 % | GEL | GALDERMA CANADA INC | MARKETED | DIN 02297809 |
| NORITATE | 1 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02156091 |
| METROCREAM - CRM 0.75% | .75 % | CREAM | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02226839 |
| METROLOTION | 0.75 % | LOTION | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02248206 |
| ROSASOL | 1.0 % | CREAM | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02242919 |
Who else supplies METRONIDAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METRONIDAZOLE appears in 2910 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.